comparemela.com

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) CEO Backer Marianne De sold 72,995 shares of Vir Biotechnology stock in a transaction on Wednesday, April 3rd. The stock was sold at an average price of $9.46, for a total transaction of $690,532.70. Following the sale, the chief executive officer now owns 678,457 shares of the […]

Related Keywords

China , ,Vir Biotechnology Company Profile ,Nasdaq ,Vir Biotechnology Inc ,Securities Exchange Commission ,China Universal Asset Management Co ,Fifth Third Bancorp ,Jpmorgan Chase Co ,Quadrant Capital Group ,Third Bancorp ,Vir Biotechnology ,Get Free Report ,Exchange Commission ,Capital Group ,Universal Asset Management ,Captrust Financial Advisors ,Financial Advisors ,Vir Biotechnology Daily ,Nasdaq Vir ,Ivir ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.